Kits Eyecare (TSE:KITS) Price Target Cut to C$23.00 by Analysts at Desjardins

Kits Eyecare (TSE:KITS) had its target price cut by Desjardins from C$25.00 to C$23.00 in a research note issued to investors on Thursday morning,BayStreet.CA reports. They currently have a buy rating on the stock.

Separately, ATB Cormark Capital Markets decreased their target price on shares of Kits Eyecare from C$20.00 to C$16.75 and set a “speculative buy” rating for the company in a research report on Thursday. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of C$20.69.

Kits Eyecare Price Performance

Kits Eyecare stock opened at C$11.57 on Thursday. Kits Eyecare has a 1 year low of C$11.12 and a 1 year high of C$22.56. The company has a market capitalization of C$393.26 million, a PE ratio of 128.56 and a beta of 0.46.

Kits Eyecare (TSE:KITS) last released its quarterly earnings data on Wednesday, May 6th. The company reported C$0.06 earnings per share (EPS) for the quarter. The firm had revenue of C$57.47 million during the quarter.

More Kits Eyecare News

Here are the key news stories impacting Kits Eyecare this week:

• Positive Sentiment: Haywood Research reiterated a Buy on KITS and framed recent share weakness as a buying opportunity despite trimming its price target to C$24, supporting near‑term investor demand. Analyst Maintains Buy on KITS
• Neutral Sentiment: Kits reported quarterly results (released May 6): C$0.06 EPS and C$57.47M revenue. Management materials and the conference call are available for details on margins and guidance; absent an obvious beat or raise, the report is currently being treated as neutral by the market. Earnings Release Press Release
• Negative Sentiment: Canaccord lowered its target from C$23.00 to C$22.00 (still a Buy), reducing implied upside and contributing to selling pressure. BayStreet.CA TickerReport
• Negative Sentiment: ATB Cormark cut its price target from C$20.00 to C$16.75 and rated the stock “speculative buy,” trimming expectations for near‑term upside. BayStreet.CA
• Negative Sentiment: Desjardins lowered its target from C$25.00 to C$23.00 while keeping a Buy rating, reducing the high‑end valuation case for the shares. BayStreet.CA
• Negative Sentiment: Stifel Nicolaus trimmed its target from C$24.00 to C$21.00 but maintained a Buy, another downward revision that narrows consensus upside. BayStreet.CA

Kits Eyecare Company Profile

KITS (TSX: KITS) is one of the world’s fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.